CAS: 1435488-37-1 - XMD17-109
Formula:C36H46N8O3
XMD17 109
CAS:1435488-37-1
Formula:
C36H46N8O3
Purity:
≥98%
Color and Shape:
Solid
Molecular weight:
638.8022
Ref: AN-AG009CFR
| 5mg | 154.00 € | |
| 25mg | 225.00 € | |
| 50mg | 506.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
XMD17-109
CAS:1435488-37-1
XMD17-109 (ERK5-IN-1) is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
Formula:
C36H46N8O3
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
638.8
Ref: TM-T1842
| 1mg | 41.00 € | |
| 2mg | 52.00 € | |
| 5mg | 85.00 € | |
| 10mg | 142.00 € | |
| 25mg | 217.00 € | |
| 50mg | 350.00 € | |
| 100mg | 527.00 € | |
| 1ml*10 (DMSO) | 108.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
Ref: 54-BISN0221
| 2mg | 188.00 € | |
| 5mg | 253.00 € | |
| 10mg | 368.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
ERK5-IN-1
CAS:1435488-37-1
Applications ERK5-IN-1 is a potent selective ERK5 inhibitor, inhibiting EGFR-induced ERK5 autophosphorylation and ERK5 enzymatic …
Formula:
C38H46N8O3
Color and Shape:
Yellow to Dark Yellow Solid
Molecular weight:
638.8
Ref: TR-E615300
| 5mg | 229.00 € | |
| 25mg | 719.00 € | |
| 100mg | 1,460.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
XMD17-109
CAS:1435488-37-1
XMD17-109 is a drug that inhibits the mitogen-activated protein kinase (MAPK) pathway, which is a …
Formula:
C36H46N8O3
Purity:
Min. 95%
Molecular weight:
638.8 g/mol
Ref: 3D-KHC48837
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
